Ironwood Pharmaceuticals (Nasdaq: IRWD), a healthcare company specializing in GI treatments, and VectivBio Holding (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe rare gastrointestinal conditions, have reached an agreement where&
Tags :Philip Frey
Orascom Development Holding successfully completed a capital increase in the amount of CHF 135 million. The transaction consisted of
Meyer Burger Technology successfully completed a capital increase raising gross proceeds of approximately CHF 250 million. The transaction consisted
